Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor
Clinical trial NCT05065021 · UNKNOWN
Trial details
- NCT number
- NCT05065021
- Sponsor
- University Health Network, Toronto
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-23
- Primary completion
- 2025-06-06
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.